Detalles de la búsqueda
1.
PD-1 blockade and allogeneic hematopoietic stem cell transplantation in Hodgkin lymphoma, a matter of time: a national study on behalf of the Société Francophone de Greffe de Moelle et de Thérapie Cellulaire.
Haematologica;
2024 06 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-38867585
2.
Graft-versus-host-disease prophylaxis with ATG or PTCY in patients with lymphoproliferative disorders undergoing reduced intensity conditioning regimen HCT from one antigen mismatched unrelated donor.
Bone Marrow Transplant;
59(5): 597-603, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38331980
3.
Thiotepa-Based Regimens Are Valid Alternatives to Total Body Irradiation-Based Reduced-Intensity Conditioning Regimens in Patients with Acute Lymphoblastic Leukemia: A Retrospective Study on Behalf of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation.
Transplant Cell Ther;
30(1): 95.e1-95.e10, 2024 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-37816471
4.
Organ complications after CD19 CAR T-cell therapy for large B cell lymphoma: a retrospective study from the EBMT transplant complications and lymphoma working party.
Front Immunol;
14: 1252811, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37828980
5.
Allogeneic hematopoietic stem cell transplantation for adults with therapy-related acute myeloid leukaemia: a retrospective multicentre study on behalf of the SFGM-TC.
Bone Marrow Transplant;
58(12): 1331-1338, 2023 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-37653054
6.
Correction: An early post-transplant relapse prediction score in multiple myeloma: a large cohort study from the chronic malignancies working party of EBMT.
Bone Marrow Transplant;
58(9): 1065, 2023 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-37316543
7.
An early post-transplant relapse prediction score in multiple myeloma: a large cohort study from the chronic malignancies working party of EBMT.
Bone Marrow Transplant;
58(8): 916-923, 2023 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-37160942
8.
Severe cytopenia after CD19 CAR T-cell therapy: a retrospective study from the EBMT Transplant Complications Working Party.
J Immunother Cancer;
11(4)2023 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-37072350
9.
Late relapse after hematopoietic stem cell transplantation for acute leukemia: a retrospective study by SFGM-TC.
Transplant Cell Ther;
29(6): 362.e1-362.e12, 2023 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-36849078
10.
Autologous versus allogeneic hematopoietic cell transplantation for older patients with acute lymphoblastic leukemia. An analysis from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation.
Bone Marrow Transplant;
58(4): 393-400, 2023 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-36611097
11.
Outcome of human umbilical cord blood stem cell transplantation (CBT) for acute myeloid leukemia in patients achieving first complete remission after one versus two induction courses: a study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT).
Bone Marrow Transplant;
57(10): 1514-1519, 2022 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-35773347
12.
Outcome after hematopoietic stem cell transplantation in patients with extranodal natural killer/T-Cell lymphoma, nasal type: A French study from the Société Francophone de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC).
Am J Hematol;
96(7): 834-845, 2021 07 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33864708
13.
Total body irradiation + fludarabine compared to busulfan + fludarabine as "reduced-toxicity conditioning" for patients with acute myeloid leukemia treated with allogeneic hematopoietic cell transplantation in first complete remission: a study by the Acute Leukemia Working Party of the EBMT.
Bone Marrow Transplant;
56(2): 481-491, 2021 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-32892216
14.
Allogeneic HCT for adults with B-cell precursor acute lymphoblastic leukemia harboring IKZF1 gene mutations. A study by the Acute Leukemia Working Party of the EBMT.
Bone Marrow Transplant;
56(5): 1047-1055, 2021 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-33235351
15.
Tandem autologous-reduced intensity allogeneic stem cell transplantation in high-risk relapsed Hodgkin lymphoma: a retrospective study of the Lymphoma Working Party-EBMT.
Bone Marrow Transplant;
56(3): 655-663, 2021 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-33046830
16.
Medication non-adherence after allogeneic hematopoietic cell transplantation in adult and pediatric recipients: a cross sectional study conducted by the Francophone Society of Bone Marrow Transplantation and Cellular Therapy.
Fundam Clin Pharmacol;
35(2): 435-445, 2021 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-32740936
17.
[Quality assessment of CAR T-cell activity: Recommendations of the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)]. / Mutualisation des outils de qualité pour les cellules CAR-T : recommandations de la Société francophone de greffe de moelle et thérapie cellulaire (SFGM-TC).
Bull Cancer;
107(12S): S193-S201, 2020 Dec.
Artículo
en Francés
| MEDLINE | ID: mdl-33187683
18.
A Retrospective Comparison of DLI and gDLI for Post-Transplant Treatment.
J Clin Med;
9(7)2020 Jul 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-32664688
19.
Comparison of reduced-intensity conditioning regimens in patients with acute lymphoblastic leukemia >45 years undergoing allogeneic stem cell transplantation-a retrospective study by the Acute Leukemia Working Party of EBMT.
Bone Marrow Transplant;
55(8): 1560-1569, 2020 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-32361712
20.
Influence of alternative donor type on early survival after hematopoietic stem cell transplantation for acute myeloid leukemia lacking a sibling donor.
Bone Marrow Transplant;
55(4): 749-757, 2020 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-31664184